Search Results - "Maples, P"
-
1
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer
Published in JNCI : Journal of the National Cancer Institute (18-02-2004)“…To evaluate the feasibility, safety, and efficacy of vaccination with autologous tumor cells genetically modified with an adenoviral vector (Ad-GM) to secrete…”
Get full text
Journal Article -
2
Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
Published in Cancer gene therapy (01-08-2009)“…In a previous dose escalation trial we demonstrated dose related survival correlation to Belagenpumatucel-L. In order to further evaluate safety and response…”
Get full text
Journal Article -
3
A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients
Published in Cancer gene therapy (01-11-2007)“…ONYX-015 is an attenuated chimeric human group C adenovirus, which preferentially replicates in and lyses tumor cells that are p53 negative. The purpose of…”
Get full text
Journal Article -
4
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
Published in Gene therapy (01-05-2001)“…Although genetically engineered adenoviruses hold promise for the treatment of cancer, clinical trial reports have utilized intratumoral injection to date. To…”
Get full text
Journal Article -
5
Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform
Published in Cancer gene therapy (01-02-2014)“…RNA interference (RNAi) represents a powerful, new tool for scientific investigation as well as a promising new form of targeted gene therapy, with…”
Get full text
Journal Article -
6
Immune response and survival of refractory cancer patients who received TGF- beta 2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine
Published in Gene therapy (01-09-2013)“…TAG vaccine is a novel 'triad vaccine' that involves transfection of autologous tumor with a dual plasmid, TGF beta 2 antisense gene and GM-CSF gene. Patients…”
Get full text
Journal Article -
7
Immune response and survival of refractory cancer patients who received TGF-β2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine
Published in Gene therapy (01-09-2013)“…TAG vaccine is a novel ‘triad vaccine’ that involves transfection of autologous tumor with a dual plasmid, TGFβ2 antisense gene and GM-CSF gene. Patients with…”
Get full text
Journal Article -
8
Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference
Published in Cancer gene therapy (01-11-2010)“…RNA interference (RNAi) is a natural cellular regulatory process that inhibits gene expression by transcriptional, post-transcriptional and translational…”
Get full text
Journal Article -
9
Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine
Published in Cancer gene therapy (01-12-2013)“…PDX1 (pancreatic and duodenal homeobox 1) is overexpressed in pancreatic cancer, and its reduction results in tumor regression. Bi-functional pbi-shRNA PDX1…”
Get full text
Journal Article -
10
P2.09 A non-viral, GNE -lipoplex treatment to correct sialylation defects in hereditary inclusion body myopathy (HIBM)
Published in Neuromuscular disorders : NMD (01-10-2010)Get full text
Journal Article -
11
Cellular immune profile of patients with advanced cancer before and after taxane treatment
Published in American journal of clinical oncology (01-10-2000)“…The purpose of this study is to determine immune recovery and function after treatment with docetaxel or paclitaxel. Peripheral blood mononuclear cells were…”
Get full text
Journal Article -
12
Proof concept for clinical justification of network mapping for personalized cancer therapeutics
Published in Cancer gene therapy (01-08-2007)“…To identify signature targets associated with patient-specific cancer lesions based on tumor versus normal tissue differential protein and mRNA coexpression…”
Get full text
Journal Article -
13
The Bloxsom Air Lock: A Historical Perspective
Published in Pediatrics (Evanston) (01-12-2001)“…In 1950, Allan P. Bloxsom (1901-1991), a pediatrician at the St Joseph Hospital in Houston, introduced his positive pressure oxygen air lock (AL) for the…”
Get full text
Journal Article -
14
Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow
Published in Experimental hematology (01-07-1993)“…The growth and differentiation of selected bone marrow CD34+ cells stimulated with hematopoietic growth factors in lipid cultures were evaluated to determine…”
Get more information
Journal Article -
15
Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer
Published in Clinical lung cancer (01-02-2001)“…Non–small-cell lung cancer frequently contains oncogenetic defects (mutations in ras, retinoblastoma, and p53 genes) that contribute to disease…”
Get full text
Journal Article -
16
Development and validation of a low-literacy Chronic Obstructive Pulmonary Disease knowledge Questionnaire (COPD-Q)
Published in Patient education and counseling (01-10-2010)“…Abstract Objective The objective of this study was to develop a content valid, understandable, readable, and reliable Chronic Obstructive Pulmonary Disease…”
Get full text
Journal Article -
17
Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer : A phase II trial
Published in Cancer research (Chicago, Ill.) (15-11-2000)“…ONYX-015 is an E1B-55kDa gene-deleted adenovirus engineered to selectively replicate in and lyse p53-deficient cancer cells. To evaluate the selectivity of…”
Get full text
Journal Article -
18
Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex
Published in Human gene therapy (01-11-2011)“…Hereditary inclusion body myopathy (HIBM) is an autosomal recessive adult-onset myopathy due to mutations in the GNE (UDP-N-acetylglucosamine…”
Get more information
Journal Article -
19
Immune response and survival of refractory cancer patients who received TGF-[beta]2 antisense/GM-CSF gene modified autologous tumor cell (TAG) vaccine
Published in Gene therapy (01-09-2013)“…TAG vaccine is a novel 'triad vaccine' that involves transfection of autologous tumor with a dual plasmid, TGF[beta]2 antisense gene and GM-CSF gene. Patients…”
Get full text
Journal Article -
20
Differential expression of alpha- and beta-globin genes in erythroleukemic cell lines
Published in Molecular and Cellular Biology (01-07-1990)“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article